top of page

Rare Spinal Cord Condition Flagged as Potential Adverse Effect of COVID-19 Vaccines: EU Drug Regulat


The European Union’s drug regulator has indicated that a change to the product information for COVID-19 vaccines from AstraZeneca and Johnson & Johnson has been recommended to include a warning of a rare spinal cord condition called transverse myelitis.

 
 
 

Comentários


bottom of page